The invention relates to a polymorphic form of [5-fluoro-3-({2-[(4- fluorobenzene)sulfonyl]pyridin-3-yl}methyl)-2- methylindol-l-yl]- acetic acid which has higher solublity than other forms and is therefore useful for preparing stable pharmacetical formulations.